Notably, the deregulation (i.e., aberrant upregulation) of FOXM1 has been reported to be a key driver of neo-oncogenesis and cancer progression, and was found to be associated with poor prognosis in several human malignancies, including lung cancer [34,35]. Here, FOXM1 is linked to lung carcinoma.